Form 6-K - Report of foreign issuer [Rules 13a-16 and 15d-16]:
SEC Accession No. 0001193125-16-752384
Filing Date
2016-10-31
Accepted
2016-10-31 07:06:04
Documents
14
Period of Report
2016-10-31

Document Format Files

Seq Description Document Type Size
1 FORM 6-K d282037d6k.htm 6-K 34386
2 GRAPHIC g282037tx03.jpg GRAPHIC 55794
3 GRAPHIC g282037tx04.jpg GRAPHIC 271656
4 GRAPHIC g282037tx05.jpg GRAPHIC 250495
5 GRAPHIC g282037tx06.jpg GRAPHIC 133566
6 GRAPHIC g282037tx07.jpg GRAPHIC 236348
7 GRAPHIC g282037tx08.jpg GRAPHIC 160706
8 GRAPHIC g282037tx09.jpg GRAPHIC 131251
9 GRAPHIC g282037tx10.jpg GRAPHIC 191663
10 GRAPHIC g282037tx11.jpg GRAPHIC 111526
11 GRAPHIC g282037tx12.jpg GRAPHIC 138882
12 GRAPHIC g282037tx13.jpg GRAPHIC 145998
13 GRAPHIC g282037tx14.jpg GRAPHIC 245767
14 GRAPHIC g282037tx15.jpg GRAPHIC 21880
  Complete submission text file 0001193125-16-752384.txt   2893954
Mailing Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077
Business Address LEVEL 5 20 GEORGE STREET HORNSBY NSW C3 2077 01161298780088
NOVOGEN LTD (Filer) CIK: 0001075880 (see all company filings)

EIN.: 000000000 | Fiscal Year End: 0630
Type: 6-K | Act: 34 | File No.: 000-29962 | Film No.: 161959996
SIC: 2834 Pharmaceutical Preparations